Companies / Japan
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Homegrown Firms Improve Business Focus
September 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
With signs that the merger fever in Japan's pharmaceutical sector is cooling, newly merged local firms are improving their business focus. Daiichi-Sankyo, the indigenous sector's second-largest firm by sales, is to divest its reagents, chemicals and imaging businesses to two Japanese corporate